Evoke Pharma competitorsClear all

Evoke Pharma's top competitors include Biogen, MyoKardia, Athersys and Reata Pharmaceuticals.
Evoke Pharma
Evoke Pharma
Evoke Pharma is a specialty pharmaceutical company focused primarily on the development of drugs to treat gastrointestinal (GI) diseases.
Biogen
Biogen
Biogen is a biopharmaceutical company that discovers, develops and delivers innovative therapies for people living with serious neurological and neurodegenerative diseases.
MyoKardia
MyoKardia
MyoKardia discovers, develops and commercializes targeted therapies for the treatment of serious and neglected rare cardiovascular diseases.
Athersys
Athersys
Athersys, a biopharmaceutical company, discovers and develops therapeutic products for the treatment of several disease indications.
Reata Pharmaceuticals
Reata Pharmaceuticals
Reata Pharmaceuticals is a biopharmaceutical company focused on translating innovative science into breakthrough medicines for intractable diseases.
Founding Date
Founding Date
2007
Founding Date
1978
Founding Date
2012
Founding Date
1995
Founding Date
2002
Type
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Solana Beach, US HQ
Locations
Cambridge, US HQ
Vicente López, AR
North Ryde, AU
Wien, AT
Machelen, BE
Mississauga, CA
see more
Locations
South San Francisco, US HQ
Locations
Cleveland, US HQ
Canton, US
Locations
Irving, US HQ
Employees
Employees
614% decrease
Employees
7,8007% increase
Employees
1024% increase
Employees
7514% increase
Employees
12332% increase
Valuation ($)
Valuation ($)
15.3 m
Valuation ($)
44.3 b
Valuation ($)
2.2 b
Valuation ($)
241.1 m
Valuation ($)
N/A
Twitter followers
Twitter followers
N/A
Twitter followers
26.4 k
Twitter followers
619
Twitter followers
1.2 k
Twitter followers
672
Number of tweets (last 30 days)
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
48
Number of tweets (last 30 days)
6
Number of tweets (last 30 days)
4
Number of tweets (last 30 days)
13
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
24.9
Average likes per tweet (last 30 days)
5.8
Average likes per tweet (last 30 days)
21.3
Average likes per tweet (last 30 days)
2.1
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
84.62%
Alexa Website Rank
Alexa Website Rank
794378
Alexa Website Rank
83540
Alexa Website Rank
337057
Alexa Website Rank
609659
Alexa Website Rank
787661

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
$11.4b (FY, 2016)
Revenue (est.)
N/A
Revenue (est.)
$24.3m (FY, 2018)
Revenue (est.)
N/A
Net income
Net income
($7.6m) (FY, 2018)
Net income
$3.7b (FY, 2016)
Net income
($67.7m) (FY, 2018)
Net income
N/A
Net income
($80.5m) (FY, 2018)

Operating

Patents (US)
Patents (US)
N/A
Patents (US)
N/A
Patents (US)
4 (FY, 2017)
Patents (US)
21 (FY, 2016)
Patents (US)
N/A
Patents Issued
Patents Issued
N/A
Patents Issued
N/A
Patents Issued
N/A
Patents Issued
200 (FY, 2016)
Patents Issued
240 (FY, 2016)
Phase I Trials Products
Phase I Trials Products
N/A
Phase I Trials Products
4 (FY, 2016)
Phase I Trials Products
2 (FY, 2017)
Phase I Trials Products
N/A
Phase I Trials Products
2 (FY, 2016)
Phase II Trials Products
Phase II Trials Products
N/A
Phase II Trials Products
10 (FY, 2016)
Phase II Trials Products
1 (FY, 2017)
Phase II Trials Products
N/A
Phase II Trials Products
4 (FY, 2016)
Phase III Trials Products
Phase III Trials Products
N/A
Phase III Trials Products
2 (FY, 2016)
Phase III Trials Products
N/A
Phase III Trials Products
N/A
Phase III Trials Products
1 (FY, 2016)

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
$ 98m
Total funding raised
$ 9m
Total funding raised
$ 468.9m
For sources of this data, please see the company profile

View company profiles

Biogen
HQ
Cambridge, US
Employees
7,800↑ 7% increase

Biogen is a biopharmaceutical company that discovers, develops and delivers innovative therapies for people living with serious neurological and neurodegenerative diseases.

View company
MyoKardia
HQ
South San Francisco, US
Employees
102↑ 4% increase

MyoKardia discovers, develops and commercializes targeted therapies for the treatment of serious and neglected rare cardiovascular diseases.

View company
Athersys
HQ
Cleveland, US
Employees
75↑ 14% increase

Athersys, a biopharmaceutical company, discovers and develops therapeutic products for the treatment of several disease indications.

View company
Reata Pharmaceuticals
HQ
Irving, US
Employees
123↑ 32% increase

Reata Pharmaceuticals is a biopharmaceutical company focused on translating innovative science into breakthrough medicines for intractable diseases.

View company